Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China flag China · Delayed Price · Currency is CNY
10.18
-0.22 (-2.12%)
May 20, 2026, 11:44 AM CST

SHE:002399 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
13,85115,73514,15215,34517,09022,787
Market Cap Growth
-2.17%11.19%-7.78%-10.21%-25.00%-3.74%
Enterprise Value
13,65815,79115,45619,08319,99224,281
Last Close Price
10.4011.7910.4711.4912.4716.56
PE Ratio
40.1145.0221.88-23.4994.63
Forward PE
17.9318.6420.6624.0614.6431.09
PS Ratio
2.562.872.682.832.393.58
PB Ratio
1.131.301.161.281.381.98
P/TBV Ratio
1.441.671.511.661.812.62
P/FCF Ratio
9.599.897.11---
P/OCF Ratio
8.969.196.4538.53--
EV/Sales Ratio
2.522.882.933.512.793.82
EV/EBITDA Ratio
14.0517.7915.00180.7015.7122.01
EV/EBIT Ratio
22.3227.8421.09-20.0229.13
EV/FCF Ratio
9.469.927.76---
Debt / Equity Ratio
0.270.250.290.460.520.49
Debt / EBITDA Ratio
3.313.233.3338.644.954.98
Debt / FCF Ratio
2.261.871.78---
Net Debt / Equity Ratio
-0.020.010.080.270.240.15
Net Debt / EBITDA Ratio
-0.260.160.9630.082.371.57
Net Debt / FCF Ratio
-0.170.090.50-81.01-3.08-8.62
Asset Turnover
0.310.320.290.270.360.33
Inventory Turnover
0.800.770.590.670.841.11
Quick Ratio
1.101.141.100.760.941.19
Current Ratio
2.152.322.602.132.222.25
Return on Equity (ROE)
3.04%2.82%5.17%-6.58%5.97%2.01%
Return on Assets (ROA)
2.26%2.09%2.51%-0.68%3.13%2.73%
Return on Invested Capital (ROIC)
4.47%3.80%4.45%-1.42%6.00%6.18%
Return on Capital Employed (ROCE)
5.00%4.50%5.40%-1.50%6.60%5.80%
Earnings Yield
2.75%2.22%4.57%-5.10%4.26%1.06%
FCF Yield
10.43%10.12%14.07%-0.26%-5.73%-0.88%
Dividend Yield
2.42%1.23%2.39%-0.80%0.21%
Payout Ratio
110.79%123.27%24.72%-34.51%171.31%
Buyback Yield / Dilution
0.01%0.00%0.72%-0.67%-0.05%-8.42%
Total Shareholder Return
2.44%1.23%3.11%-0.67%0.75%-8.21%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.